|
Market Closed -
OTC Markets
14:57:29 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 41.90 USD | +2.46% |
|
-0.17% | +15.23% |
| 09-25 | US FDA approves Mirum's drug for rare bone disorder | RE |
| 09-22 | European Pharma Leaders Push for National Reforms to Boost Investment | DJ |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Ipsen(IPN)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Ipsen(IPN)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Ipsen(IPN)
EBIT
Dividend / Share (DPS)
Data source:
Ipsen(IPN)
Cash or Net Debt
- Stock Market
- Stocks
- IPN Stock
- IPSEY Stock
- Consensus Ipsen S.A.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
